Loading...
XHKG
1302
Market cap1.07bUSD
Dec 05, Last price  
1.90HKD
1D
-3.55%
1Q
-4.04%
Jan 2017
2.15%
IPO
660.00%
Name

LifeTech Scientific Corp

Chart & Performance

D1W1MN
XHKG:1302 chart
P/E
34.15
P/S
5.83
EPS
0.05
Div Yield, %
Shrs. gr., 5y
1.19%
Rev. gr., 5y
14.28%
Revenues
1.30b
+2.88%
104,704,000140,324,000181,475,000231,035,000282,679,000311,606,000352,849,000409,125,000556,698,000668,879,000642,299,000925,334,0001,097,310,0001,267,175,0001,303,699,000
Net income
222m
-15.52%
3,936,00011,830,00032,352,000-65,666,000-81,244,0002,359,000145,652,000163,472,000121,082,000129,200,000216,085,000292,472,000325,337,000263,242,000222,388,000
CFO
321m
-23.10%
44,755,00011,790,00042,523,00034,963,00019,527,000144,313,000126,956,000154,891,000182,300,000274,986,000338,532,000488,853,000388,318,000418,049,000321,460,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; manufacturing and trading of materials for hemp; staff training and internal personnel management business; information consulting for investors; and manufacturing and trading of medical devices, as well as technical, consulting, and technology services. It has operations in Mainland China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.
IPO date
Nov 10, 2011
Employees
1,393
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT